A Dual-Agonist Overview Tirzepatide is a synthetic peptide that acts as a dual agonist of the GLP-1 and GIP receptors
Typical weightloss results on semaglutide, tirzepatide, and others Although typical weight-loss results on semaglutide, tirzepatide, and other GLP-1 medications can vary, both semaglutide and tirzepatide have been seen to help provide meaningful average weight loss
In the KLOW configuration, BPC157 and TB500 emphasize tissue repair and vascular support, KPV provides antiinflammatory and gutimmune balance, and GHKCu drives collagen and ECMcentric regeneration, producing a broad regenerative and antiinflammatory profile
These agents have both hormonal and brain targets
Loss of weight from GLP-1 agonists may also help with psychological hindrances to libido, like low self-esteem from previous stigmatization